DIVIS LABORATORIES
Back to Income Statement
|
DIVIS LABORATORIES Last 5 Year Total Expenditure History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Expenditure | ₹6,393 Cr | ₹5,639 Cr | ₹5,398 Cr | ₹507,872 Cr | ₹4,108 Cr |
What is the latest Total Expenditure of DIVIS LABORATORIES ?
| Year | Total Expenditure |
|---|---|
| Mar2026 | ₹6,393 Cr |
| Mar2025 | ₹5,639 Cr |
| Mar2024 | ₹5,398 Cr |
| Mar2023 | ₹507,872 Cr |
| Mar2022 | ₹4,108 Cr |
How is Total Expenditure of DIVIS LABORATORIES Trending?
| Years | Total Expenditure | % Change | |
|---|---|---|---|
| Mar2026 | ₹6,393 Cr | 13.37 | |
| Mar2025 | ₹5,639 Cr | 4.46 | |
| Mar2024 | ₹5,398 Cr | -98.94 | |
| Mar2023 | ₹507,872 Cr | 12,261.98 | |
| Mar2022 | ₹4,108 Cr | - | |
Compare Total Expenditure of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹244,601.2 Cr | -3.3% | -0.2% | 63.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,562.0 Cr | -3.2% | -7.8% | 14.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹180,871.0 Cr | -2.4% | -5% | 33.6% | Stock Analytics | |
| CIPLA | ₹107,770.0 Cr | -4% | -5.6% | -10.2% | Stock Analytics | |
| MANKIND PHARMA | ₹102,433.0 Cr | 1.7% | 4.2% | 1.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,829.0 Cr | -1.2% | 4.1% | -4.2% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | -3.3% |
-0.2% |
63.3% |
| SENSEX | -2.1% |
-5.9% |
-10.8% |
You may also like the below Video Courses